在线报刊亭
Pharmaceuticals and Healthcare Reports China Dyslipidemia Market 点击阅读
  • 评论

Pharmaceuticals and Healthcare Reports

China Dyslipidemia Market

出版日期 / “健康与健身, 健康与健身” / 语言—English / 3页
More so than in any other market, the statins dominated Chinese dyslipidemia drugs sales in the 2013 base year, contributing 84% to the total market share, reflecting sales of $1.7 billion in total sales 更多
下载
免费订阅

“ Pharmaceuticals and Healthcare Reports”的其他出版物

查看所有出版物

相关的杂志